Literature DB >> 12720548

p300/CBP-associated factor (P/CAF) interacts with nuclear respiratory factor-1 to regulate the UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase-3 gene.

Hiroto Izumi1, Ryo Ohta, Gunji Nagatani, Tomoko Ise, Yoshifumi Nakayama, Minoru Nomoto, Kimitoshi Kohno.   

Abstract

We demonstrated recently that expression of the UDP- N -acetyl-alpha-D-galactosamine: polypeptide N -acetylgalactosaminyltrans-ferase-3 (GalNAc-T3) gene is restricted to epithelial glands [Nomoto, Izumi, Ise, Kato, Takano, Nagatani, Shibao, Ohta, Imamura, Kuwano, Matsuo, Yamada, Itoh and Kohno (1999) Cancer Res. 59, 6214-6222]. In the present study, we show that sodium butyrate treatment of human breast cancer MCF-7 cells transcriptionally activates the GalNAc-T3 gene. Transient transfection of plasmids containing a reporter gene under the control of GalNAc-T3 indicated that several transcriptional elements are involved in response to sodium butyrate, with the nuclear respiratory factor-1 (NRF-1)-binding motif located between -88 and -77nt being the most important. Incubation of a labelled probe encompassing the NRF-1-binding motif with a nuclear extract of sodium butyrate-treated MCF-7 cells yielded a higher level of specific DNA-protein complex versus controls. Flag-tagged NRF-1 expressed in MCF-7 cells can bind to the NRF-1-binding motif of the GalNAc-T3 promoter. Nuclear content of NRF-1 remained constant in MCF-7 cells treated with or without sodium butyrate. Moreover, NRF-1 interacts with and is acetylated by p300/CBP-associated factor (P/CAF). Acetylation of NRF-1 enhances DNA binding. Co-transfection of the GalNAc-T3 reporter plasmid with either NRF-1 or P/CAF expression plasmid resulted in the activation of the GalNAc-T3 promoter. These results indicate a correlation between acetylation of NRF-1 by P/CAF and the butyrate-induced expression of the GalNAc-T3 gene. Additionally, induced expression of P/CAF may be a component of the adenocarcinoma differentiation process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12720548      PMCID: PMC1223531          DOI: 10.1042/BJ20021902

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Oxidative stress and upregulation of mitochondrial biogenesis genes in mitochondrial DNA-depleted HeLa cells.

Authors:  S Miranda; R Foncea; J Guerrero; F Leighton
Journal:  Biochem Biophys Res Commun       Date:  1999-04-29       Impact factor: 3.575

2.  p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.

Authors:  L Liu; D M Scolnick; R C Trievel; H B Zhang; R Marmorstein; T D Halazonetis; S L Berger
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family.

Authors:  K G Ten Hagen; F K Hagen; M M Balys; T M Beres; B Van Wuyckhuyse; L A Tabak
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

4.  Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry.

Authors:  M Moriuchi; H Moriuchi; W Turner; A S Fauci
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

5.  Structural basis for the regulation of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase-3 gene expression in adenocarcinoma cells.

Authors:  M Nomoto; H Izumi; T Ise; K Kato; H Takano; G Nagatani; K Shibao; R Ohta; T Imamura; M Kuwano; K Matsuo; Y Yamada; H Itoh; K Kohno
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

6.  A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates.

Authors:  E P Bennett; H Hassan; M A Hollingsworth; H Clausen
Journal:  FEBS Lett       Date:  1999-10-29       Impact factor: 4.124

7.  Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.

Authors:  H Huang; C P Reed; J S Zhang; V Shridhar; L Wang; D I Smith
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

8.  Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase that displays glycopeptide N-acetylgalactosaminyltransferase activity.

Authors:  K G Ten Hagen; D Tetaert; F K Hagen; C Richet; T M Beres; J Gagnon; M M Balys; B VanWuyckhuyse; G S Bedi; P Degand; L A Tabak
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

9.  Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.

Authors:  E P Bennett; H Hassan; U Mandel; M A Hollingsworth; N Akisawa; Y Ikematsu; G Merkx; A G van Kessel; S Olofsson; H Clausen
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

10.  Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNF alpha promoter in stimulated mast cells.

Authors:  V Novotny; E E Prieschl; R Csonga; G Fabjani; T Baumruker
Journal:  Nucleic Acids Res       Date:  1998-12-01       Impact factor: 16.971

View more
  17 in total

Review 1.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

2.  Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation.

Authors:  Junwei Zeng; Rongjuan Mi; Yingchun Wang; Yujing Li; Li Lin; Bing Yao; Lina Song; Irma van Die; Arlene B Chapman; Richard D Cummings; Peng Jin; Tongzhong Ju
Journal:  J Biol Chem       Date:  2015-06-10       Impact factor: 5.157

3.  Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors.

Authors:  Pelin Balcik-Ercin; Metin Cetin; Irem Yalim-Camci; Gorkem Odabas; Nurettin Tokay; A Emre Sayan; Tamer Yagci
Journal:  Cell Oncol (Dordr)       Date:  2018-03-07       Impact factor: 6.730

4.  Mucin-Type O-GalNAc Glycosylation in Health and Disease.

Authors:  Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

5.  Transcriptional regulation of insulin-degrading enzyme modulates mitochondrial amyloid β (Aβ) peptide catabolism and functionality.

Authors:  María C Leal; Natalia Magnani; Sergio Villordo; Cristina Marino Buslje; Pablo Evelson; Eduardo M Castaño; Laura Morelli
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

6.  Promoter regulation of the visinin-like subfamily of neuronal calcium sensor proteins by nuclear respiratory factor-1.

Authors:  Jian Fu; Jirong Zhang; Fang Jin; Jamie Patchefsky; Karl-Heinz Braunewell; Andres J Klein-Szanto
Journal:  J Biol Chem       Date:  2009-08-12       Impact factor: 5.157

7.  Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.

Authors:  Kentaro Kato; Hideyuki Takeuchi; Akira Kanoh; Naoki Miyahara; Yoko Nemoto-Sasaki; Megumi Morimoto-Tomita; Azusa Matsubara; Yoshimi Ohashi; Michihiko Waki; Katsuaki Usami; Ulla Mandel; Henrik Clausen; Nobuaki Higashi; Tatsuro Irimura
Journal:  Glycoconj J       Date:  2010-02       Impact factor: 2.916

8.  Activation of cyclin D1 affects mitochondrial mass following traumatic brain injury.

Authors:  Pampa Saha; Rajaneesh Gupta; Tanusree Sen; Nilkantha Sen
Journal:  Neurobiol Dis       Date:  2018-07-18       Impact factor: 5.996

Review 9.  After the banquet: mitochondrial biogenesis, mitophagy, and cell survival.

Authors:  Jianhui Zhu; Kent Z Q Wang; Charleen T Chu
Journal:  Autophagy       Date:  2013-05-03       Impact factor: 16.016

10.  Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.

Authors:  Motoaki Sano; Sam C Wang; Manabu Shirai; Fernando Scaglia; Min Xie; Satoshi Sakai; Toru Tanaka; Prathit A Kulkarni; Philip M Barger; Keith A Youker; George E Taffet; Yasuo Hamamori; Lloyd H Michael; William J Craigen; Michael D Schneider
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.